Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma.

Feldman, E R

Phase II trial of recombinant tumor necrosis factor in disseminated malignant melanoma. [electronic resource] - American journal of clinical oncology Jun 1992 - 256-9 p. digital

Publication Type: Clinical Trial; Journal Article; Research Support, U.S. Gov't, P.H.S.

0277-3732

10.1097/00000421-199206000-00015 doi


Adult
Aged
Drug Evaluation
Female
Humans
Male
Melanoma--drug therapy
Middle Aged
Recombinant Proteins--therapeutic use
Remission Induction
Survival Analysis
Tumor Necrosis Factor-alpha--therapeutic use